Pharmacist Who Dishonestly Took Medicines From Pharmacy Shows Sufficient Insight for Suspension to End
Date of Decision: October 7, 2026
Registrant's Role: Pharmacist
Allegations:
- On several occasions between July and August 2024, the registrant removed prescription-only medication containing codeine from the pharmacy for personal use or benefit. This was admitted and found proved.
- On several occasions in August 2024, the registrant removed the prescription-only medication "Onepeaze" for personal use or benefit. The registrant admitted one occasion, but the allegation was found proved in its entirety.
- The registrant ordered and/or removed Naramig 2.5 mg tablets for personal use or benefit: 15 May 2024: six packs; 20 July 2024: four packs; 30 July 2024: four packs; 2 August 2024: Naramig 2.5 mg tablets; 16 August 2024: four packs.
- The proved actions were dishonest because the registrant did not pay for the medication and knew they were not entitled to remove it.
Outcome: Fitness to practise no longer impaired
Case Summary
Allegations
This case concerns a pharmacist whose dishonest removal of medicines from a community pharmacy led to misconduct findings and suspension. At a review hearing on 7 October 2026, the GPhC Fitness to Practise Committee considered whether the registrant had sufficiently addressed the concerns to return to practice when the existing suspension expired.
The underlying allegations involved repeated removal of prescription-only medicines for the registrant’s own use or benefit. These included medication containing codeine, Onepeaze, and several packs of Naramig 2.5 mg tablets. The conduct occurred between May and August 2024.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.
